1,517
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Necessity of addressing motivations for cannabis use to guide research

&

References

  • Wall MM, Liu J, Hasin DS, Blanco C, Olfson M. Use of marijuana exclusively for medical purposes. Drug Alcohol Depend. 2019;195:13–15.
  • Sarne Y. Beneficial and deleterious effects of cannabinoids in the brain: the case of ultra-low dose THC. Am J Drug Alcohol Abuse. 2019;45:551–562. doi: 10.1080/00952990.2019.1578366.
  • Burggren AC, Shirazi A, Ginder N, London ED. Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives. Am J Drug Alcohol Abuse. 2019;45:563–562. doi: 10.1080/00952990.2019.1634086.
  • Tashkin DP, Roth MD. Pulmonary effects of inhaled cannabis smoke. Am J Drug Alcohol Abuse. 2019;45:596–609. doi: 10.1080/00952990.2019.1627366.
  • Ginsburg BC. Strengths and limitations of two cannabis-impaired driving detection methods: a review of the literature. Am J Drug Alcohol Abuse. 2019;45:610–622. doi: 10.1080/00952990.2019.1655568.
  • Hasin DS, Shmulewitz D, Sarvet AL. Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings. Am J Drug Alcohol Abuse. 2019;45:623–643. doi: 10.1080/00952990.2019.1569668.
  • Cooper ZD, Abrams DI. Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: A comprehensive review of randomized-controlled studies. Am J Drug Alcohol Abuse. 2019;45:580–595. doi: 10.1080/00952990.2019.1669628.
  • Caulkins JP, Kilborn ML. Cannabis legalization, regulation, & control: a review of key challenges for local, state, and provincial officials. Am J Drug Alcohol Abuse. 2019;45:689–697. doi: 10.1080/00952990.2019.1611840.
  • Kilmer B. How will cannabis legalization affect health, safety, and social equity outcomes? It largely depends on the 14 Ps. Am J Drug Alcohol Abuse. 2019;45:664–672. doi: 10.1080/00952990.2019.1611841.
  • Shover CL, Humphreys K. Six policy lessons relevant to cannabis legalization. Am J Drug Alcohol Abuse. 2019;45:698–706. doi: 10.1080/00952990.2019.1569669.
  • Adinoff B, Reiman A. Implementing social justice in the transition from illicit to legal cannabis. Am J Drug Alcohol Abuse. 2019;45:673–688. doi: 10.1080/00952990.2019.1674862.
  • Gruber SA, Sagar KA, Dahlgren MK, Gonenc A, Smith RT, Lambros AM, Cabrera KB, Lukas SE. The grass might be greener: medical marijuana patients exhibit altered brain activity and improved executive function after 3 months of treatment. Front Pharmacol. 2018;8:983
  • Smart R, Pacula RL. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: findings from state policy evaluations. Am J Drug Alcohol Abuse. 2019;45:644–663. doi: 10.1080/00952990.2019.1669626.
  • Shover CL, Davis CS, Gordon SC, Humphreys K. Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proc Natl Acad Sci. 2019;116:12624–26.
  • Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010. JAMA Intern Med. 2014;174:1668–73.
  • Bradford AC, Bradford WD. Medical marijuana laws may be associated with a decline in the number of prescriptions for medicaid enrollees. Health Aff (Millwood). 2017;36:945–51.
  • Bradford AC, Bradford WD, Abraham A, Bagwell Adams G. Association between US state medical cannabis laws and opioid prescribing in the medicare Part D population. JAMA Intern Med. 2018;178:667.
  • National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington (DC): National Academies Press (US); 2017.
  • National Institutes of Health. NIH to investigate minor cannabinoids and terpenes for potential pain-relieving properties. National Institutes of Health; 2019. Available from: https://www.nih.gov/news-events/news-releases/nih-investigate-minor-cannabinoids-terpenes-potential-pain-relieving-properties [accessed 10 May 2019].
  • Drug Enforcement Administration. DEA announces steps necessary to improve access to marijuana research. Drug Enforcement Administration; 2019. Available from: https://www.dea.gov/press-releases/2019/08/26/dea-announces-steps-necessary-improve-access-marijuana-research [accessed 10 May 2019].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.